ECM
KRRO icon

EMC Capital Management’s Korro Bio KRRO Stock Holding History

EMC Capital Management’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-541
Closed -$139K – 337
2021
Q4 		$139K Hold
541
– – 0.07% 91
2021
Q3 		$170K Buy
+541
New +$213K 0.09% 96
2021
Q2 		– Sell
-600
Closed -$285K – 131
2021
Q1 		$285K Buy
600
+7
+1% +$13.6K 0.2% 84
2020
Q4 		$1.05M Buy
+593
New +$783K 0.8% 37

Other funds holding KRRO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

EMC Capital Management's KRRO Position: Q1 2022 in Review

EMC Capital Management sold out of Korro Bio (KRRO) in Q1 2022, closing a stake of 541 shares — an estimated $139K sold.

EMC Capital Management first reported a position in KRRO in Q4 2020 and held it in 4 quarters. The position peaked at $1.05M in Q4 2020. 85 funds tracked by Wall St. Rank hold KRRO as of Q1 2022.

  • EMC Capital Management reported no remaining Korro Bio position as of Q1 2022 after selling out during the quarter.
  • EMC Capital Management sold 541 Korro Bio shares in Q1 2022, an estimated $139K.
  • EMC Capital Management first reported a position in Korro Bio in Q4 2020 and held it in 4 quarters.
  • EMC Capital Management's Korro Bio position peaked at $1.05M in Q4 2020.
  • 85 funds tracked by Wall St. Rank held Korro Bio as of Q1 2022.

Based on EMC Capital Management's 13F filing for Q1 2022, filed 16 May 2022.